ovarian cancer; advanced endometroid; peritoneal cancer; fallopian tube cancer.

A Newly-Approved Drug Combination Slows the Progression of Advanced Ovarian Cancer

Post author:Rose Duesterwald
Post published:May 12, 2020
Post category:Ovarian Cancer Rare Disease

Lynparaza is back in the news again, but this time, according to Cure Today, the FDA approved the drug in combination with Avastin for advanced ovarian cancer to prevent progression…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More